First trial of gene-editing treatment for haemophilia

Image credit: James St. John/CC BY 2.0

The first attempt to edit the genes of cells inside the human body is about to take place. The technique being trialled aims to cure haemophilia B, a clotting disorder that can result in spontaneous internal bleeding.

The trial was announced in Washington DC this week at the International Summit on Human Gene Editing.

Read the full article in New Scientist.

Advertisements